Skip to main content

Birth Defect clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for
  • Clinical Utility of Pediatric Whole Exome Sequencing

    Sorry, in progress, not accepting new patients

    The investigator aims to examine the clinical utility of WES, including assessment of a variety of clinical outcomes in undiagnosed pediatric cases.

    at UCSF

  • Hydrops: Diagnosing & Redefining Outcomes With Precision Study

    Sorry, accepting new patients by invitation only

    This is a national, prospective study designed to investigate the genetic etiologies of non-immune hydrops fetalis (NIHF) and other birth defects. At least half of prenatally diagnosed NIHF cases remain of unknown etiology after standard work up, and a substantial proportion of other birth defects remain of unknown etiology as well. The investigators are performing exome sequencing (ES) for the affected fetus or neonate in unexplained cases, as well as enrolling cases with a genetic explanation to represent the full spectrum of diseases underlying NIHF and other birth defects.

    at UCSF

Our lead scientists for Birth Defect research studies include .

Last updated: